BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND NT5C2, ENSG00000076685, 22978, P49902, PNT5, NT5B, GMP, cN-II AND Treatment
10 results:

  • 1. High-Load Gemcitabine Inorganic-Organic Hybrid Nanoparticles as an Image-Guided Tumor-Selective Drug-Delivery System to Treat Pancreatic cancer.
    Ischyropoulou M; Sabljo K; Schneider L; Niemeyer CM; Napp J; Feldmann C; Alves F
    Adv Mater; 2023 Nov; 35(46):e2305151. PubMed ID: 37587542
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression.
    Lv T; Xiong X; Yan W; Liu M; Xu H; He Q
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35688553
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Hypoxia-induced RNASEH2A limits activation of cGAS-STING signaling in HCC and predicts poor prognosis.
    Zhao F; Liu A; Gong X; Chen H; Wei J; Chen B; Chen S; Yang R; Fan Y; Mao R
    Tumori; 2022 Feb; 108(1):63-76. PubMed ID: 34165025
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
    Bozward AG; Warricker F; Oo YH; Khakoo SI
    Front Immunol; 2021; 12():643310. PubMed ID: 33995362
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
    Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists.
    Liu B; Tang L; Zhang X; Ma J; Sehgal M; Cheng J; Zhang X; Zhou Y; Du Y; Kulp J; Guo JT; Chang J
    Antiviral Res; 2017 Nov; 147():37-46. PubMed ID: 28982551
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.
    Kumazoe M; Takai M; Hiroi S; Takeuchi C; Yamanouchi M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Yamada S; Kangawa K; Takahashi T; Tanaka H; Tachibana H
    Sci Rep; 2017 May; 7(1):1917. PubMed ID: 28507327
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo.
    Xiao H; Noble GT; Stefanick JF; Qi R; Kiziltepe T; Jing X; Bilgicer B
    J Control Release; 2014 Jan; 173():11-7. PubMed ID: 24511610
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Vascular proliferation is associated with survival in pancreatic ductal adenocarcinoma.
    Hoem D; Straume O; Immervoll H; Akslen LA; Molven A
    APMIS; 2013 Nov; 121(11):1037-46. PubMed ID: 23489215
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells.
    Shimizu M; Suzui M; Deguchi A; Lim JT; Xiao D; Hayes JH; Papadopoulos KP; Weinstein IB
    Clin Cancer Res; 2004 Oct; 10(19):6710-21. PubMed ID: 15475462
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.